These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30851639)

  • 1. SFX-01 reduces residual disability after experimental autoimmune encephalomyelitis.
    Galea I; Copple IM; Howat DW; Franklin S
    Mult Scler Relat Disord; 2019 May; 30():257-261. PubMed ID: 30851639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain in experimental autoimmune encephalitis: a comparative study between different mouse models.
    Lu J; Kurejova M; Wirotanseng LN; Linker RA; Kuner R; Tappe-Theodor A
    J Neuroinflammation; 2012 Oct; 9():233. PubMed ID: 23039175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of exercise in a relapsing-remitting model of experimental autoimmune encephalomyelitis.
    Klaren RE; Stasula U; Steelman AJ; Hernandez J; Pence BD; Woods JA; Motl RW
    J Neurosci Res; 2016 Oct; 94(10):907-14. PubMed ID: 27312674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
    J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis.
    Stolz L; Derouiche A; Devraj K; Weber F; Brunkhorst R; Foerch C
    J Neuroinflammation; 2017 Jul; 14(1):152. PubMed ID: 28754118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
    Xie C; Ciric B; Yu S; Zhang GX; Rostami A
    J Neuroimmunol; 2016 Feb; 291():59-69. PubMed ID: 26857496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
    Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
    J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinematic gait parameters are highly sensitive measures of motor deficits and spinal cord injury in mice subjected to experimental autoimmune encephalomyelitis.
    Fiander MD; Stifani N; Nichols M; Akay T; Robertson GS
    Behav Brain Res; 2017 Jan; 317():95-108. PubMed ID: 27639322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the effects of potentially therapeutic modified peptides on polyclonal T cell populations in a mouse model of multiple sclerosis.
    Sauer EL; Trifilieff E; Greer JM
    J Neuroimmunol; 2017 Jun; 307():18-26. PubMed ID: 28495132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2013 Sep; 98():122-31. PubMed ID: 23973432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
    Zarruk JG; Berard JL; Passos dos Santos R; Kroner A; Lee J; Arosio P; David S
    Neurobiol Dis; 2015 Sep; 81():93-107. PubMed ID: 25724358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maladaptive cortical hyperactivity upon recovery from experimental autoimmune encephalomyelitis.
    Ellwardt E; Pramanik G; Luchtman D; Novkovic T; Jubal ER; Vogt J; Arnoux I; Vogelaar CF; Mandal S; Schmalz M; Barger Z; Ruiz de Azua I; Kuhlmann T; Lutz B; Mittmann T; Bittner S; Zipp F; Stroh A
    Nat Neurosci; 2018 Oct; 21(10):1392-1403. PubMed ID: 30258239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
    Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
    Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
    Pryor WM; Freeman KG; Larson RD; Edwards GL; White LJ
    J Neurosci Res; 2015 May; 93(5):697-706. PubMed ID: 25510644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold nanoparticles and polyethylene glycol alleviate clinical symptoms and alter cytokine secretion in a mouse model of experimental autoimmune encephalomyelitis.
    Aghaie T; Jazayeri MH; Avan A; Anissian A; Salari AA
    IUBMB Life; 2019 Sep; 71(9):1313-1321. PubMed ID: 30957389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
    Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis.
    Simon M; Ipek R; Homola GA; Rovituso DM; Schampel A; Kleinschnitz C; Kuerten S
    J Neuroinflammation; 2018 Aug; 15(1):225. PubMed ID: 30098594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
    Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
    J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Anti-Inflammatory Effect of Sulforaphane in Mice with Experimental Autoimmune Encephalomyelitis.
    Yoo IH; Kim MJ; Kim J; Sung JJ; Park ST; Ahn SW
    J Korean Med Sci; 2019 Jul; 34(28):e197. PubMed ID: 31327180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: implications for the treatment of multiple sclerosis.
    Hammer LA; Zagon IS; McLaughlin PJ
    Brain Res Bull; 2015 Mar; 112():42-51. PubMed ID: 25647234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.